Russians Use Chloropicrin Ammunition In Tavria Direction - Military


(MENAFN- UkrinForm) Ukrainian military and civilians did not suffer from the use of chloropicrin in the Tavria direction on Monday.

Spokesman for the Tavria Defense Forces Valeriy Shershen said this on the air of the nationwide telethon "United News", an Ukrinform correspondent reports.

"Our military, as well as civilians, were not affected. There are no casualties, and there are no injuries to our people. We have enough means of defense against such shells," Shershen assured.

According to him, the enemy fired two times on Monday afternoon and in the late afternoon with chemical munitions. It has been preliminarily established that it was chlorpicrin. "Contact with chloropicrin causes severe irritation of the eyes, nose, throat, and respiratory tract. There are other various symptoms," the spokesman added.

Read also: defense forces destroy eight enemy ammo depots in tavria direction

Chlorpicrin is a pesticide of limited use, but it was used as a chemical weapon during the First World War. The drug is harmful to humans and can be absorbed systemically by inhalation, swallowing, and skin. In high concentrations, it is highly irritating to the lungs, eyes, and skin. The Chemical Weapons Convention prohibits the military use of chloropicrin, but Russia has repeatedly used it during the invasion of Ukraine.

As reported, the commander of the Tavria operational and strategic grouping of troops, General Oleksandr Tarnavsky, said on August 7 that Russian troops had once again violated the rules of war and used chemical munitions against Ukrainian defenders.

The shelling took place near Novodanylivka.

MENAFN08082023000193011044ID1106812098


UkrinForm

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.